Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-26 @ 12:52 AM
Study NCT ID:
NCT00494234
Status:
COMPLETED
Last Update Posted:
2024-01-19
First Post:
2007-06-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2009-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-27
First Submit QC Date:
None
Study First Post Date:
2007-06-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-16
Results First Submit QC Date:
None
Results First Post Date:
2015-01-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-09-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-01-18
Last Update Post Date:
2024-01-19
Last Update Post Date Type:
ACTUAL